Balwani Shut Down $96M Investor's Due Diligence, Jury Told

By Bonnie Eslinger · May 18, 2022, 10:52 PM EDT

A hedge fund manager testified Wednesday in the fraud trial of former Theranos executive Ramesh "Sunny" Balwani that before his firm and its affiliates invested $96.1 million he tried to do...

To view the full article, register now.